LifeArc backs 15 patient studies into ‘re-purposed’ therapies to fight coronavirus

£10m in grants mean patient enrolment can begin immediately Medical research charity LifeArc is providing £10m for…

LifeArc and MRC partnership creates new £16m fund to establish Gene Therapy Innovation Hubs

The Medical Research Council (MRC) and independent medical research charity LifeArc are making £16m available to establish…

LifeArc provides £2m to the University of Edinburgh STOPCOVID initiative

LifeArc provides £2m to the STOPCOVID project, which aims to test existing and experimental drugs to find a treatment for COVID-19

LifeArc launches £10 million research fund to address the challenges of COVID-19

Today, LifeArc, a UK-based medical research charity, has created a £10 million fund to support research to…

LifeArc announces seed fund investment in start-up GyreOx

The funding will support a two-year programme to develop and automate GyreOx’s proprietary drug discovery platform, MACRO.

LifeArc boosts investment in Cambridge University spin-out PolyProx Therapeutics to advance new class of cancer medicines

The investment will help advance studies to validate polyproxin® molecules as potential drug candidates across a range of cancers.

LifeArc and Scottish Government Chief Scientist Office launch new funding scheme to boost translational research in Scotland

Funding aims to progress strong discovery science to a point where additional substantive funding could be secured.

LifeArc marks Rare Disease Day 2020 with a call for more translational research

Translational research can turn promising science into new treatments for those with rare diseases. It’s why we…

Celebrating the International Day of Women and Girls in Science

LifeArc celebrates the UN’s International day of Women and Girls in Science, joining the call to remove any barriers that hold women back.